LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis (UC)
50 locations incl. Phoenix
Sponsor: Eli Lilly and Company
Sex: All·Age: 18 - 80
Code: NCT07415044·Phase 2·Recruiting·Listed Feb 2026
Treasure Valley Medical Research
Clinical research site in Boise, Idaho · Treasure Valley Medical Research, 1000 N Curtis Rd Ste 102, Boise, ID 83706 · (208) 813-6505 · Website
As of July 2026, 10 paid clinical trials are recruiting at Treasure Valley Medical Research in Boise, Idaho. Active studies at this site cover conditions such as Chronic Inducible Urticaria, Atopic Dermatitis and Chronic Idiopathic Constipation (CIC). Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at Treasure Valley Medical Research (10)
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
for Chronic Idiopathic Constipation (CIC)
109 locations incl. Foley
Sponsor: Ardelyx
Sex: All·Age: 18 - 80
Code: NCT07382167·Phase 3·Recruiting·Listed Feb 2026
A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)
for Chronic Inducible Urticaria
26 locations incl. Birmingham
Sponsor: Celldex Therapeutics
Sex: All·Age: 18+
Code: NCT07266402·Phase 3·Recruiting·Listed Dec 2025
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
for Atopic Dermatitis
66 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 18 - 63
Code: NCT06389136·Phase 3·Recruiting·Listed Apr 2024
A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy
for Hidradenitis Suppurativa
78 locations incl. Birmingham
Sponsor: AbbVie
Sex: All·Age: 12+
Code: NCT05889182·Phase 3·Recruiting·Listed Jun 2023
A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo
for NonSegmental Vitiligo
69 locations incl. Birmingham
Sponsor: Incyte Corporation
Sex: All·Age: 2 - 11
Code: NCT06548360·Phase 3·Recruiting·Listed Aug 2024
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
for Crohn's Disease
56 locations incl. Dothan
Sponsor: AbbVie
Sex: All·Age: 18 - 75
Code: NCT06548542·Phase 2·Recruiting·Listed Aug 2024
A Study of Lebrikizumab (LY3650150) in Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)
for Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
41 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 12+
Code: NCT06338995·Phase 3·Recruiting·Listed Apr 2024
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
for Atopic Dermatitis
26 locations incl. Little Rock
Sponsor: AbbVie
Sex: All·Age: 2 - 11
Code: NCT06461897·Phase 3·Recruiting·Listed Jun 2024
Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)
for Chronic Inducible Urticaria
27 locations incl. Birmingham
Sponsor: Blueprint Medicines Corporation
Sex: All·Age: 18+
Code: NCT06931405·Phase 2·Recruiting·Listed Apr 2025
More research sites in Boise
- Saint Luke's Cancer Institute - Boise (81 trials)
- Saint Alphonsus Cancer Care Center-Boise (59 trials)
- St. Luke's Boise Medical Center (6 trials)
- Saint Alphonsus Regional Medical Center (5 trials)
- Boise VA Medical Center (4 trials)
- Advanced Specialty Research (3 trials)
- Consultants in Epilepsy and Neurology, PLLC (3 trials)
- ASR, LLC (3 trials)
- St. Luke's Cancer Institute: Boise (3 trials)
- Ascendis Investigational Site (2 trials)